Clinical studies have Reported following Adverse Events With An Incidence Of More Than 2% In Placebo-Controlled Allergic Rhinitis Clinical Trials In Patients 12 Years Of Age And Older (Percent Of Patients): Headache(12%), somnolence (8%), fatigue (4%) Dry Mouth (3%).
Drug Abuse And Dependence: There is no information to indicate that abuse or dependency occurs with loratadine.